Skip to main content

Diagnostic Delay of Venous Thromboembolism (DOVE) in Primary Care

CBE ID
3749e
Endorsement Status
Endorsed
1.1 New or Maintenance
New
Previous Endorsement Cycle
Spring 2023
Is Under Review
No
Next Maintenance Cycle
Spring 2028
E&M Cycle Comments

Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Spring 2023 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Spring 2023 “Intent to Submit.” Battelle took over the E&M work for the Spring 2023 cycle when developers and/or stewards submitted their full measure information, which for CBE #3749e, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2023-06/3749e_-_diagnostic_delay_of_venous_thromboembolism_dove_in_primary_care.zip

To close out this E&M cycle, Battelle published the Spring 2023 measures for pre-evaluation public commenting, convened the E&M standing committees for their measure evaluation meetings, launched the Spring 2023 post-comment period, convened the E&M committees for the post-comment meeting, convened the CSAC to render a final endorsement decision, and executed the appeals period.

 

1.3 Measure Description

This eCQM assesses the rate of delayed diagnosis of VTE in adults aged 18 years and older in the primary care setting. Delayed diagnosis is defined as diagnosis of VTE that occurs >24 hours following the index primary care visit where symptoms for the VTE were first present (within 30 days).

    • 1.14 Numerator

      The subset of the denominator where the patient’s VTE diagnosis occurs greater than 24 hours following a primary care visit (within 30 days).

    • 1.15 Denominator

      All adult patients (age 18 years and older) presenting in primary care with VTE-related symptoms, who are subsequently diagnosed with VTE following a primary care visit (within 30 days).

    • Exclusions

      This eCQM excludes patients who received hospice or palliative care within 90 days of the eligible VTE event.

    • OLD 1.12 MAT output not attached
      Attached
    • Most Recent Endorsement Activity
      Patient Safety Spring 2023
      Initial Endorsement
    • Steward
      Brigham and Women's Hospital
    • Risk Adjustment
      No risk adjustment or risk stratification
      Risk adjustment approach
      Off
      Risk adjustment approach
      Off
      Conceptual model for risk adjustment
      Off
      Conceptual model for risk adjustment
      Off